Your Web Site
Teva Receives First U.S. Approval for Generic Pulmicort Respules®; Commences Commercial Launch...
JERUSALEM----Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has granted approval for the Company’s Abbreviated New Drug Application to market its generic version of...
